Signs point to upturn in pharma commercialization M&A in 2024
Several factors are coming together to create the right conditions for a major upturn in dealmaking in the pharma commercialization sector.
Stay updated with breaking news from Primus Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Several factors are coming together to create the right conditions for a major upturn in dealmaking in the pharma commercialization sector.
BioProcure and Prendio Announce Strategic Growth Investment From Primus ...
Rev.io, a provider of automated billing and customer management solutions, is acquiring Tigerpaw's business automation software.
/PRNewswire/ -- Rev.io, a leading provider of automated billing and customer management solutions to telecommunications businesses, wireless and mobility...
/PRNewswire/ -- Aquiline Capital Partners LLC ("Aquiline"), a private investment firm based in New York and London with $9.2 billion in assets under...